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It is intuitive to speculate that nutrient availability may
influencedifferentiationofmammaliancells.Nonethe-
less, a comprehensive complement of the molecular
determinants involved in this process has not been
elucidated yet. Here, we have investigated how nutri-
ents (glucose) affect skeletal myogenesis. Glucose
restriction (GR) impaired differentiation of skeletal
myoblasts and was associated with activation of the
AMP-activated protein kinase (AMPK). Activated
AMPK was required to promote GR-induced tran-
scription of the NAD+ biosynthetic enzyme Nampt. In-
deed, GR augmented the Nampt activity, which con-
sequently modified the intracellular [NAD+]:[NADH]
ratio and nicotinamide levels, andmediated inhibition
of skeletal myogenesis. Skeletal myoblasts derived
from SIRT1+/ heterozygous mice were resistant to
the effects of either GR or AMPK activation. These
experiments reveal that AMPK, Nampt, and SIRT1
are the molecular components of a functional signal-
ing pathway that allows skeletal muscle cells to sense
and react to nutrient availability.
INTRODUCTION
The execution of essential and specialized functions relies on the
cell’s ability to sense and adapt to the environment, with nutrient
availability being one of the most critical variables. The nema-
tode C. elegans reacts to overcrowding and unfavorable nutrient
conditions by entering the dauer diapause, a nonfeeding, resis-
tant to oxidative stress, and long-lived larval developmental
stage (Cassada and Russell, 1975). Moreover, decreasing calo-
rie intake is the sole intervention that successfully increases life
span across species (Masoro, 2006). A mechanistic understand-
ing of these phenomena requires the identification of the mole-
cules that mediate the cellular response to nutrients.
Although their role on lifespan is still a matter of intense debate
(Chen and Guarente, 2007; Kaeberlein and Powers, 2007; LongoDand Kennedy, 2006; Michan and Sinclair, 2007), it is well estab-
lished that the sirtuins—a family of evolutionarily conserved
deacetylases—play important roles in numerous physiological
processes (Haigis and Guarente, 2006). By deacetylating cofac-
tors such as PCAF (Fulco et al., 2003; Brunet et al., 2004), p300
(Motta et al., 2004; Brunet et al., 2004), PGC-1a (Nemoto et al.,
2005; Rodgers et al., 2005), and numerous transcriptional activa-
tors, the NAD+-dependent deacetylase sirtuin SIRT1 controls
critical functions of mammalian cell physiology including stress
resistance (Vaziri et al., 2001; Luo et al., 2001; Cohen et al.,
2004), replicative senescence (Chua et al., 2005), aging, and
differentiation (Blander and Guarente, 2004). Differentiation of
skeletal muscle cells (Fulco et al., 2003) and adipocytes (Picard
et al., 2004), angiogenesis (Potente et al., 2007), survival of neu-
rons (Araki et al., 2004) and pancreatic b cells (Kitamura et al.,
2005), insulin secretion (Bordone et al., 2006; Moynihan et al.,
2005), lipid (Li et al., 2007) and liver metabolism (Rodgers
et al., 2005), and increased physical activity during calorie
restriction (Chen et al., 2005) are all regulated by SIRT1.
In contrast to class I-II histone deacetylases (HDACs), the en-
zymatic activity of SIRT1 is modulated by physiological cofac-
tors and inhibitors. NAD+ is an obligate cosubstrate (Imai et al.,
2000), whereas NADH (Lin et al., 2004) and nicotinamide (NAM)
are inhibitors of SIRT1 (Bitterman et al., 2002). The central role
of the NAD+ salvage pathway in regulating the enzymatic activity
of Sir2—the SIRT1 yeast ortholog—is illustrated by the observa-
tion that the nicotinamidase PNC1—the yeast functional equiva-
lent of mammalian NAM phosphoribosyltransferase (Nampt;
also known as PBEF or visfatin)—is both necessary and suffi-
cient for life span extension caused by calorie restriction and
low-intensity stress in a Sir2-dependent fashion (Anderson
et al., 2003). Moreover, Nampt retards senescence of cultured
human cells (van der Veer et al., 2007). Overexpression of exog-
enous Nampt regulates the transcriptional activity of a transiently
transfected Gal-SIRT1 fusion protein in mammalian cells (Re-
vollo et al., 2004). Nampt was recently identified as a stress-
and nutrient-responsive gene that increases mitochondrial
NAD+ levels and promotes survival during genotoxic stress via
the mitochondrial sirtuins SIRT3 and SIRT4 (Yang et al., 2007).
Even though it remains unclear as to what the relative contribu-
tion of increased [NAD+]:[NADH] ratio versus reduced NAM is,evelopmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc. 661
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modifications in NAD+ and NAM levels are likely to be the most
important regulators of sirtuin activity (Grubisha et al., 2005). De-
spite a wealth of information on the molecules and mechanisms
that mediate the effects of SIRT1 on several biological processes
(Michan and Sinclair, 2007), the identification and mechanistic
elucidation of the signals that activate the NAD+ salvage path-
way and, as a consequence, regulate the deacetylase activity
of SIRT1 and of other sirtuins in response to nutrient availability
and oxidative stress in mammalian cells remains to be fully un-
derstood. Within this context, an attractive candidate is the
AMP-activated protein kinase (AMPK). AMPK activation is ob-
served in fasting and calorie-restricted animals and it has been
proposed as a one of the several mechanisms involved in regu-
lating mammal longevity (McCarty, 2004). In agreement with this
hypothesis—and, similarly, to Sir2—extra copies of AMPK can
extend life span in C. elegans (Apfeld et al., 2004) and mediate
the effects of dietary restriction on longevity through the FOXO
transcription factors (Greer et al., 2007a). Finally, the SIRT1
agonist resveratrol—shown to augment survival of mice on
a high-calorie diet (Baur et al., 2006) and improve mitochondrial
function (Lagouge et al., 2006)—induces phosphorylation and ac-
tivationofAMPK(Bauretal., 2006; Dasguptaand Milbrandt, 2007).
Skeletal muscle cell differentiation is accompanied by modifi-
cations of the [NAD+]:[NADH] ratio that exerts regulatory func-
tions on SIRT1(Sartorelli and Caretti, 2005). A decrease of
the [NAD+]:[NADH] ratio coincides with skeletal myogenesis,
whereas an increase inhibits it (Fulco et al., 2003). The regulatory
function of the [NAD+]:[NADH] ratio offers the opportunity to
investigate whether a link exists between the mechanisms that
preside to differentiation and those that mediate the response
to nutrient availability in skeletal muscle cells. Here, we report
that GR causes AMPK activation and prevents proper differenti-
ation of mouse skeletal muscle cells. Activated AMPK is required
to induce Nampt transcription, thus increasing intracellular
[NAD+]:[NADH] ratio and lowering NAM levels. Blockade of either
AMPK or Nampt counteracts the effects of GR, and, conversely,
activation of AMPK, in normocaloric conditions, augments intra-
cellular [NAD+]:[NADH] ratio, reduces NAM levels, and mimics
GR. Inhibition of cell differentiation induced by GR, AMPK activa-
tion, or Nampt is dependent on SIRT1 because skeletal myo-
blasts derived from SIRT1+/ heterozygous animals are less
sensitive to either GR or AMPK activation and continue to differ-
entiate in extremely low caloric conditions. These findings pro-
vide an initial description and mechanistic explanation of how
mammalian skeletal muscle cells sense, decode, and respond
to nutrient availability through a series of highly regulated enzy-
matic reactions leading to modifications of metabolic parame-
ters consonant with promoting activation of SIRT1.
RESULTS
Glucose-Restriction-Mediated Activation of AMPK
Prevents Differentiation of Skeletal Muscle Cells
We investigated the effect of reducing the glucose levels—the
major source of calories in the culture medium—on the differen-
tiation process of either C2C12 skeletal muscle cell line or mouse
primary skeletal myoblasts. Cells cultured in low glucose—5 mM
or lower concentrations—failed to appropriately differentiate, as662 Developmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc.indicated by reduced expression of the sarcomeric myosin
heavy chain (MHC), caveolin-3, and impaired formation of multi-
nucleated myotubes (Figures 1A–1C, see Figure S1A in the Sup-
plemental Data available with this article online). Primary skeletal
myoblasts differentiated in 5 mM glucose (data not shown),
showing defective differentiation only at a lower glucose concen-
tration (0.5 mM) (Figure 1C). Within the time frame of our exper-
iments (48 hr in differentiation medium [DM]), GR did not induce
apoptosis, and, once normocaloric conditions were re-estab-
lished, cells resumed differentiation (Figures S1B and S1C). We
evaluated whether fatty acids—which are effectively utilized by
the mitochondrial metabolism—could overcome the effects of
low glucose by exposing C2C12 cells to 0.1 mM oleic acid. Oleic
acid promoted differentiation (Hurley et al., 2006) but was inef-
fective in counteracting the differentiation defects exerted by
low glucose (Figure S1D), indicating that increased b oxidation
fueled by lipids is insufficient to compensate for glucose reduc-
tion. As expected, cells cultured with low glucose had decreased
intracellular ATP levels (Figure 1D). In response to ATP depletion,
AMPK is phosphorylated and activated (Hardie et al., 2006). Ac-
cordingly, progressive reduction of glucose induced phosphory-
lation of AMPK and of its substrate acetyl-CoA-carboxylase
(ACC) in C2C12 cells (Figure 1E). To evaluate whether AMPK ac-
tivation is sufficient to recapitulate the effects of GR, we em-
ployed the AMP mimetic 5-aminoimidazole-4-carboxamide-1-
beta-D-ribofuranoside (AICAR) (Kemp et al., 1999). AMPK is re-
quired for AICAR-stimulated glucose uptake in skeletal muscle,
indicating that this AMP mimetic is a specific activator of
AMPK in this tissue (Mu et al., 2001). AICAR promoted AMPK
and ACC phosphorylation in normocaloric (NC) conditions
(Figure 1F), and cells exposed to AICAR in NC conditions failed
to appropriately differentiate (Figures 1G and 1H). In addition
to AICAR, two other AMPK activators—the furancarboxylic
acid derivative D942 (Kosaka et al., 2005) and the hypoglycemic
drug metformin (Zhou et al., 2001)—also inhibited cell differenti-
ation in a dose-dependent manner (Figures S1E and S1F). To
test whether AMPK activation is necessary to mediated GR,
we retrovirally transduced an AMPK dominant negative
(AMPK-DN) construct—bearing the K45R mutation in the a-2
catalytic subunit of rat AMPK (Mu et al., 2001)—in myoblasts.
Cells that received the AMPK-DN efficiently differentiated de-
spite the GR conditions (Figures 1I and 1J) and were refractory
to AICAR-induced block of differentiation (Figure 1K). Moreover,
compound C, an AMPK inhibitor (Zhou et al., 2001), also rescued
the GR-induced differentiation defects of both C2C12 cells and
primary skeletal myoblasts (Figures S1G and S1H). Thus,
AMPK activation is required to mediate the effects of GR on skel-
etal muscle differentiation.
Glucose Restriction and AMPK Require SIRT1
Because the SIRT1 ortholog Sir2 mediates the effects of calorie
restriction in yeast (Lin et al., 2000) and counteracts skeletal
myogenesis in mammalian cells (Fulco et al., 2003), we evalu-
ated the potential involvement of SIRT1 in mediating the effects
of GR on skeletal muscle differentiation. NAM—a sirtuin inhibitor
(Bitterman et al., 2002)—rescued differentiation of GR cells
(Figure 2A), suggesting that the deacetylase activity of sirtuins
is relevant in mediating the effects of CR. NAM inhibits the de-
acetylase activities of several sirtuins. Therefore, we assessed
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Effectors of Glucose Restriction in Muscle CellsFigure 1. Glucose Restriction Inhibits Differentiation of Skeletal Myoblasts and Activates AMPK
(A) C2C12 cells were differentiated in a medium (differentiation medium [DM]) supplemented with either 25 mM or 5 mM glucose for 48 hr. Immunofluorescence
(IF) was performed with a MHC antibody. DAPI marks the cell nuclei. The fusion index reported throughout this study was determined as described in the
Experimental Procedures (p < 0.05).
(B) Immunoblot for MHC, caveolin-3, and tubulin proteins from cell extracts derived from C2C12 cells cultured as in (A).
(C) Mouse primary myoblasts were cultured in DM with either 25 mM or 0.5 mM glucose for 48 hr. IF was performed as in (A).
(D) The ATP levels were determined in extracts of C2C12 cells cultured in DM with either 25 mM or 5 mM glucose.
(E) Phosphorylation of AMPK (pT172) and of the AMPK substrate ACC (pS79) in C2C12 cells cultured in DM with 25 mM, 5 mM, or 2.5 mM glucose determined by
immunoblot with phospho-specific AMPK and ACC antibodies. The total levels of AMPK and ACC were determined with AMPK and ACC antibodies.
(F) C2C12 cells were exposed to AICAR (0.5 mM), and AMPK and ACC phosphorylation was evaluated as in (E).
(G) C2C12 cells were cultured in DM with 25 mM glucose and exposed to either vehicle (DMSO) or AICAR (0.5 mM) for 36 hr. IF was performed with an MHC
antibody.
(H) MHC and tubulin immunoblot of extracts of the cells described in (G).
(I) C2C12 cells transduced with a retrovirus expressing a dominant negative form of AMPK (myc-tagged AMPK-DN) were cultured in DM supplemented with either
25 mM or 5 mM glucose. IF was performed with an MHC antibody.
(J) Immunoblot of extracts derived from the cells described in (I) with the MHC, myc, and tubulin antibodies.
(K) MHC, myc, and GAPDH immunoblot of extracts derived from the cells expressing myc-AMPK-DN exposed to AICAR (0.5 mM).the specific role of SIRT1 in GR by reducing its levels with a ret-
rovirus expressing a short hairpin RNA predicted to target solely
the SIRT1 messenger RNA (mRNA) (shSIRT1). Under these con-
ditions, the differentiation ability was efficiently rescued, even
when the cells were cultured in very low glucose conditions
(2.5 mM glucose) (Figures 2B and 2C). In contrast, small interfer-
ing RNA (siRNA)-mediated knockdown of two other mitochon-
drial sirtuins—SIRT3 and SIRT4—was ineffective in preventing
GR-mediated inhibition of cell differentiation (Figure S2). To un-
equivocally test for SIRT1 involvement, we isolated skeletal myo-
blasts derived from mice with germline mutation of the SIRT1Dgene. Because SIRT1/ homozygous mice are perinatal lethal
(McBurney et al., 2003), we compared the response to GR of
primary myoblasts isolated from 4-week-old wild-type and
SIRT1+/ heterozygous mice. Despite the extreme GR regimen
(0.5 mM glucose), SIRT1+/ primary myoblasts efficiently acti-
vated muscle gene expression and differentiated, whereas the
cells derived from wild-type littermates were impaired in these
processes (Figures 2D and 2E). Neither the SIRT1 transcripts
nor the protein levels were affected by GR in C2C12 cells, WT,
orSIRT1+/ myoblasts (Figures 2B, 2D, and 2F). Thus, myoblasts
cultured in low glucose are impaired in their differentiationevelopmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc. 663
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Effectors of Glucose Restriction in Muscle CellsFigure 2. SIRT1 Mediates the Effects of Glucose Restriction on Skeletal Myoblasts
(A) Extracts of C2C12 cells cultured in DM with either 25 mM or 5 mM glucose and without or with NAM (5 mM) were immunoblotted with the MHC, caveolin-3, and
tubulin antibodies.
(B) C2C12 cells were transduced with a retrovirus expressing a RNA hairpin directed against SIRT1 (shSIRT1) and cultured in DM with 25 mM, 5 mM, or 2.5 mM
glucose. Immunoblot was performed with antibodies against MHC, SIRT1, and tubulin.
(C) MHC IF of cells expressing control or hSIRT1 cultured in DM with 25 mM or 5 mM glucose.
(D) RT-qPCR of transcripts (embryonic myosin heavy chain Myh3, troponin C2, and SIRT1) derived from freshly isolated mouse primary skeletal myoblasts of
4-week-old wild-type (WT) or SIRT1+/ heterozygous mice cultured in DM with 25 mM or 0.5 mM glucose. Three independently obtained RNA samples were
evaluated. The values of each transcript were corrected for those of GAPDH transcripts. Error bars represent standard deviations (p < 0.05).
(E) MHC IF of WT and SIRT1+/ skeletal myoblasts cultured in DM with 25 mM or 0.5 mM glucose.
(F) SIRT1 and tubulin immunoblot of extracts from mouse primary myoblasts obtained from either WT or SIRT1+/ heterozygous animals cultured in either 25 mM
or 0.5 mM glucose.process and SIRT1 is required to mediate this phenomenon. We
then asked whether AMPK also requires SIRT1. When SIRT1
levels were reduced, the cells became partially refractory to
AICAR (Figures 3A–3C). Similarly, myoblasts from SIRT1+/ ani-
mals differentiated despite the presence of AICAR in the culture
medium (Figure 3D). The residual inhibitory effect of AICAR on
cell differentiation (on either shSIRT1 C2C12 cells or SIRT1+/
myoblasts) is likely due to the remaining SIRT1. SIRT1 was
also required for the effects of the AMPK activator D942
(Figure S1E). Overall, the results of the experiments reported in
this paragraph indicate that the effects of either GR or AMPK
on skeletal myogenesis require SIRT1.664 Developmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc.Modulation of Gene Expression by GR
To identify genes transcriptionally modulated by glucose, we
performed whole-genome microarray analysis of C2C12 cells
grown in either 25 mM or 5 mM glucose. In addition to transcripts
for structural and regulatory muscle proteins, numerous others
involved in glucose and lipid metabolism, xenobiotic detoxifica-
tion, mitochondrial energy production, and respiration were
modulated by GR (Gene Expression Omnibus database at
http://www.ncbi.nlm.nih.gov/geo/ and Table S1). Expression of
several transcripts was verified by reverse transcription-quanti-
tative polymerase chain reaction (RT-qPCR) (data not shown
and Figure S3). Downregulation of glycolysis is a hallmark of
Developmental Cell
Effectors of Glucose Restriction in Muscle CellsFigure 3. AMPK Activation Recapitulates the Effects of Glucose Restriction and Is SIRT1 Dependent
(A) MHC, SIRT1, and tubulin immunoblot of extracts of C2C12 cells expressing shSIRT1 cultured in 25 mM glucose and exposed to increasing (0.25–0.5 mM)
concentrations of AICAR for 36 hr.
(B and C) MHC IF (B) and myogenin and Myh3 transcripts (C) of cells described in (A). V, DMSO; A, AICAR. Error bars represent standard deviations.
(D) MHC IF of mouse primary skeletal myoblasts from WT or SIRT1+/ heterozygous mice cultured in DM with DMSO (vehicle) or AICAR (0.5 mM) for 36–48 hr.calorie restriction and it has been suggested as one of the mech-
anisms that mediates its effects (Ingram et al., 2006; Hipkiss,
2006). Accordingly, the transcripts of the glycolytic genes phos-
phoglycerate mutase (PGAM), phosphofructokinase, and beta
enolase were reduced (Table S1 and Figures S3A and S3B). Ex-
pression of the phosphoglycerate mutase, beta enolase, and
phosphofructokinase was also reduced in skeletal muscles of
mice subjected to a 48 hr fasting (Figure S3B). Conversely,
the UDP-glucuronosyltransferase 1, epoxide hydrolase 1(Epx1)
and glutathione S transferase (GST) (xenobiotic detoxification),
and Gadd45 gamma (stress-induced) transcripts were increased
in GR cells (Table S1 and Figure S3C). As observed in C. elegans
subjected to dietary glucose restriction (Schulz et al., 2007), sev-
eral transcripts encoding for proteins involved in lipid metabo-
lism were increased, whereas a number of transcripts encoding
collagen or collagen-like proteins were decreased in GR cells
(Table S1, extracellular matrix). We next asked whether the mod-
ifications on gene expression induced by GR were dependent on
SIRT1 by either exposing the GR cells to NAM or by overex-
pressing SIRT1 in NC conditions. The results of these experi-
ments indicate that NAM reversed the effects of GR on gene
expression and, conversely, SIRT1 mimicked them under NC
(Figures S3A and S3C). The transcripts for the PGAM, GST,Dand Epx1genes were also evaluated in myoblasts from either
wild-type or SIRT1+/ mice. Although GR affected their expres-
sion in control myoblasts, it had no effect on SIRT1+/cells.
(Figure S4). Overall, the results of these experiments indicate
that GR induces specific modifications on the gene expression
profile and that this gene modulation involves SIRT1.
The Nampt of the NAD+ Salvage Pathway Mediates
the Effects of GR or AMPK on Cell Differentiation
in a SIRT1-Dependent Manner
Because the SIRT1 levels were not increased by GR, we consid-
ered the possibility that its enzymatic activity may be modulated.
Indeed, extracts derived from GR cells sustained an increased
SIRT1 activity (Figure 4A). SIRT1 activity is stimulated by an in-
creased [NAD+]:[NADH] ratio and/or reduced NAM levels. Given
that either GR or AMPK requires the presence of SIRT1 and its
activity is increased in GR cells, we asked whether the [NAD+]:
[NADH] ratio and NAM levels were influenced by GR or AMPK
activation. Extracts derived fromGR cells displayed a significantly
increased [NAD+]:[NADH] ratio and decreased NAM (Figures 4B
and 4C, Figure S5A). Similarly, AICAR increased SIRT1 activity
and the [NAD+]:[NADH] ratio and decreased the NAM levels (Fig-
ures 4D–4F, Figure S5B). AICAR also stimulated SIRT1 activity inevelopmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc. 665
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Effectors of Glucose Restriction in Muscle CellsFigure 4. Effects of Glucose Restriction, AMPK Activation, or Nampt on [NAD+]:[NADH] Ratio, SIRT1 Activity, and Nicotinamide Levels of
Skeletal Muscle Cells
(A) SIRT1 activity was evaluated in extracts derived from C2C12 cells cultured in DM with 25 mM or 5 mM glucose, respectively, for 24 hr.
(B and C) [NAD+]:[NADH] ratio (B) and NAM levels (C) were determined in extracts of C2C12 cells cultured in DM with 25 mM or 5 mM glucose.
(D) SIRT1 activity was evaluated in extracts derived from C2C12 cells exposed to vehicle or AICAR (0.5 mM) for 24 hr.
(E and F) [NAD+]:[NADH] ratio (E) and NAM levels (F) were evaluated in C2C12 cells cultured in DM with 25 mM glucose in the absence (vehicle, V) or presence (A)
of AICAR.
(G) Schematic representation of the SIRT1-mediated deacetylation reaction and NAD+ salvage pathway.
(H) Nampt enzymatic activity in extracts of C2C12 cells cultured in DM with 25 mM or 5 mM glucose.
(I) Nampt enzymatic activity in extracts of C2C12 cells cultured in DM with 25 mM glucose in the absence (V) or presence (A) of AICAR.
(J) Nampt and GAPDH immunoblot of C2C12 cells expressing a RNA hairpin against Nampt (shNampt).
(K) [NAD+]:[NADH] ratio in cells expressing shNampt cultured in DM with 25 mM or 5 mM glucose.
(L) MHC IF of control or shNampt-expressing C2C12 cells cultured in DM with 25 mM or 5 mM glucose. All of the enzymatic measurements reported in this figure
were repeated with three independent samples. Error bars represent standard deviations.wild-type mouse primary myoblasts and—consistent with the
residual inhibitory effect of AICAR on cell differentiation (Fig-
ure 3D)—inSIRT1+/myoblasts (Figure S4B). The increased intra-
cellular [NAD+]:[NADH] ratio and reduced NAM levels observed
in GR- and AICAR-treated cells are consistent with activation of
the NAD+ salvage pathway. In a highly regulated deacetylation re-
action, SIRT1 cleaves NAD+, yielding NAM, 20-30-O-acetyl ADP ri-
bose, and the deacetylated lysine (Tanny and Moazed, 2001;
Sauve et al., 2006). NAM is then employed as a precursor of
NAD+ synthesis through the NAD+ salvage pathway. In mamma-
lian cells, Nampt catalyzes the conversion of NAM and phosphor-666 Developmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc.ibosyl pyrophosphate (PRPP) into nicotinamide mononucleotide
(NMN) (Magni et al., 1999). NMN is further converted into NAD+
by the nicotinamide mononucleotide adenylyltransferase (Ema-
nuelli et al., 2001; Figure 4G). Because Nampt is the first and
rate-limiting enzyme of this pathway, we tested for its involvement
in GR- and AMPK-mediated effects on skeletal myogenesis. To
evaluate the Nampt enzymatic activity, we incubated cell extracts
derived fromskeletal muscle cells cultured in either NC or GR con-
ditions with 14C-labeled NAM (the Nampt substrate) and mea-
sured formation of 14C-labeled NMN (the final product of the
Nampt reaction). Cell extracts from either GR- or AICAR-treated
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Effectors of Glucose Restriction in Muscle CellsFigure 5. The Outcomes of AMPK Activation on Cell Differentiation Depend on Nampt and SIRT1
(A) [NAD+]:[NADH] ratio in C2C12 cells exposed to the Nampt inhibitor FK866 (10 nM) cultured in DM with either 25 mM or 5 mM glucose.
(B) MHC and tubulin immunoblot of extracts from C2C12 cells exposed to FK866 (10 nM).
(C) MHC, myogenin, caveolin-3, and tubulin immunoblot of extracts of C2C12 cells exposed to increasing concentrations (0.25–0.5 mM) of AICAR and FK866
(10 nM) in DM with 25 mM glucose.
(D) MHC, myogenin, caveolin-3, Nampt, and GAPDH immunoblot of extracts from C2C12 cells (control or shNampt) exposed to AICAR in DM with 25 mM
glucose.
(E) MHC IF of control or shNampt-expressing C2C12 cells cultured in DM with 25 mM glucose and 0.5 mM AICAR or vehicle.
(F) MHC IF of controls or myc-Nampt-expressing C2C12 cells cultured in DM with 25 mM glucose.
(G) MHC, myc, and tubulin immunoblot of extracts from the C2C12 cells described in (F).
(H) MHC, SIRT1, myc, and tubulin immunoblot of extracts from C2C12 cells expressing myc-Nampt and transfected with either control (scrambled) or SIRT1
siRNA. Cells were cultured in DM with 25 mM glucose.
(I) MHC, myc, and tubulin immunoblot of extracts from C2C12 cells expressing myc-NNMT and cultured in DM with 25 mM glucose.
(J) Immunoblot were as described in (I) with extracts from control or NNMT-expressing C2C12 cells cultured in the absence or presence of NAM (5 mM).cells sustained an increased production of 14C-NMN, compared
to extracts of NC cells (Figures 4H and 4I). The function of Nampt
was directly addressed by lowering of its levels with a retrovirus
expressing a short-hairpin-specific RNA (shNampt) (Figure 4J).
Cells with reduced Nampt did not increase the intracellular
[NAD+]:[NADH] ratio and efficiently differentiated in GR conditions
(Figures 4K and 4L, and Figure S5C). We then probed the role of
the enzymatic activity of Nampt with FK866, a highly specific in-
hibitor (Hasmann and Schemainda, 2003; Khan et al., 2006).
FK866 prevented the increase of the intracellular [NAD+]:[NADH]
ratio caused by GR and allowed differentiation of myoblasts cul-tured in GRconditions (Figures5A and 5B). To further substantiate
these findings, cells were transduced with a Nampt mutant
(A244M) that retains the phosphoribosyltransferase activity but
is FK866 insensitive (Khan et al., 2006). Because the Nampt
A244M protein escapes FK866 inhibition, these cells had an in-
creased intracellular [NAD+]:[NADH] ratio and failed to appropri-
ately differentiate, despite exposure to FK866 (Figures S6A and
S6B, middle panels). The enzymatic activity of Nampt was inacti-
vated by introduction of a mutation (S314A) within its active do-
main (Wang et al., 2006). Cells transduced with Nampt (A244M/
S314A) and exposed to FK866 failed to upregulate theDevelopmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc. 667
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Effectors of Glucose Restriction in Muscle Cells[NAD+]:[NADH] ratio and properly differentiated (Figures S6A and
S6B, right panels). Overall, these results indicate that the enzy-
matic activity of Nampt is responsible for modulating the
[NAD+]:[NADH] ratio and is associated with lack of cell differenti-
ation observed during GR. In parallel experiments, we employed
AICAR to ask whether Nampt was also required to mediate the ef-
fects of AMPK. As shown in Figures 5C–5E and Figure S7, inhibi-
tion of Nampt activity with FK866 or reduction of the Nampt levels
rendered the cells refractory to AICAR. Lastly, we investigated
whether Nampt requires SIRT1. To this end, skeletal myoblasts
were transduced with a retrovirus encoding Nampt. Under NC
conditions, cells overexpressing Nampt were impaired in their dif-
ferentiation process (Figures 5F and 5G). Reduction of SIRT1
levels resumed differentiation of Nampt-overexpressing cells,
as indicated by increased MHC expression (Figure 5H, compare
Ctr and SIRT1 siRNA lanes). In an attempt to distinguish the con-
tribution of the two possible effects mediated by Nampt (NAM de-
pletion versus increased NAD+ synthesis), we transduced C2C12
cells with a retrovirus expressing the NAM N-methyltransferase
(NNMT). NNMT is an enzyme outside of the NAD+ salvage path-
way that removes NAM by converting it to N-methyl-NAM without
boosting NAD+ biosynthesis (Aksoy et al., 1994; Anderson et al.,
2003). Cells expressing NNMT were impaired in their differentia-
tion despite being cultured with high glucose (Figure 5I). Consis-
tent with a role of NAM in this process, its addition partially re-
verted the NNMT-mediated inhibition on differentiation
(Figure 5J). Altogether, the results presented in this paragraph in-
dicate that (1) GR and AMPK activate Nampt, (2) Nampt is re-
quired for the effects exerted by GR and AMPK, (3) the effects
of Nampt on cell differentiation require SIRT1, and (4) expression
of NNMT—which reduces NAM levels (Aksoy et al., 1994)—is suf-
ficient to mimic GR.
Fasting Induces Expression of Some AMPK Target
Genes in a SIRT1-Dependent Manner
So that the role of AMPK-SIRT1 in regulating the response to
nutrient availability in vivo could be evaluated, wild-type CD1 or
SIRT1/ homozygous animals outbred on the CD1 strain were
fed ad libitum (AL) or fasted for 48 hr. We chose to analyze
SIRT1/ homozygous/CD1 mice because these animals have
no detectable SIRT1 and, in contrast to inbred SIRT1//129/Sv,
survive to adulthood (McBurney et al., 2003). Uncoupling protein
2 (UCP-2) expression is induced by AICAR (Jager et al., 2007)
and is repressed by SIRT1 in basal conditions (Bordone et al.,
2007; Moynihan et al., 2005). Compared to the fed-AL wild-type
(Figures 6A and 6B, lanes 1 and 2), UCP-2 was increased in mus-
cles of fed AL SIRT1/ mice (Figures 6A and 6B, lanes 5 and 6).
Although fasting induced UCP-2 expression in the wild-type (Fig-
ures 6A and 6B, lanes 3 and 4), it failed to further increase the
already elevated levels of UCP-2 in SIRT1/ animals (Figures
6A and 6B, lanes 7 and 8). A similar behavior was noted for expres-
sion of uncoupling protein 3 (UCP-3)—another gene whose ex-
pression is induced by AICAR (Jager et al., 2007) and repressed
by SIRT1 (Amat et al., 2007; Figures 6A and 6B) and for the pyru-
vate kinase-4 (PDK4) (Figure 6A). In contrast, expression of the
fatty acid translocase CD36—a gene activated by AICAR
(Chabowski et al., 2006)—was stimulated by fasting, irrespective
of SIRT1 (Figure 6A). Consistent with a repressive role of SIRT1
on muscle gene expression (Fulco et al., 2003), skeletal muscles668 Developmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc.of SIRT1/ had elevated levels of perinatal and embryonic myo-
sins—two isoforms that are normally repressed in the adult mus-
cle (Weydert et al., 1987). On the contrary, the nonmuscle myosin
Myl6—whose expression is not developmentally regulated—was
comparably expressed in wild-type and SIRT1/ mice (Figures
6C and 6D). Because the levels of Pax7, Myf5, cyclins D1 and E,
and PCNA—all markers of quiescent or activated and proliferating
satellite cells (Holterman and Rudnicki, 2005)—were not in-
creased (Figures S7C and S7D), we are inclined to exclude the
possibility that elevated expression of perinatal and embryonic
myosins is a reflection of muscle damage and regeneration occur-
ring inSIRT1/ animals. Overall, the results presented in this par-
agraph indicate that SIRT1 negatively regulates expression of
some AMPK targets in normocaloric conditions in vivo and is re-
quired to mediate their induction by fasting. They further indicate
that skeletal muscles of adult SIRT1/ mice retain expression
of embryonic and neonatal differentiation markers without dis-
playing signs of satellite cell activation.
Glucose Restriction Induces Nampt Transcription
via AMPK
Extracts derived from either GR- or AICAR-treated cells have an
elevated Nampt enzymatic activity (Figures 4H and 4I). There-
fore, we asked whether these two interventions might influence
Nampt transcription. After GR of skeletal muscle cells or animal
fasting, the Nampt mRNA and protein levels were increased (Fig-
ures 7A–7C). Cells exposed to AICAR had also increased Nampt
mRNA and protein levels (Figures 7D and 7E). Such increase in
Nampt was blunted in cells cultured in GR conditions and ex-
pressing an AMPK-dominant negative (AMPK-DN) form (Fig-
ure 7F), indicating that AMPK regulates GR-induced expression
of Nampt. Consonant with a lack of Nampt induction, neither the
Nampt activity nor the [NAD+]:[NADH] ratio was increased in
AMPK-DN cells exposed to GR (Figures 7G and 7H). Overall,
these experiments indicate that activated AMPK is required to
mediate transcriptional induction of Nampt occurring during GR.
DISCUSSION
SIRT1 regulates skeletal muscle differentiation in a tissue culture
system (Fulco et al., 2003), but how signals emanating from the
microenvironment control this process is not understood. More
specifically, whether and how modifications of the microenviron-
ment may impact the intracellular NAD+ biosynthesis and/or the
nicotinamide levels—and therefore modulate SIRT1 activity—in
skeletal muscle cells remains to be determined. The results of
this study indicate that skeletal myoblasts cultured in low-
glucose media are impaired in their differentiation through activa-
tion of a pathway that targets the enzymatic activity of SIRT1. The
lack of proper differentiation when nutrients are scarce may be
simplistically interpreted as the result of passive adaptation of
cells incapable of sustaining energy-demanding processes,
such as those associated with modification of gene expression,
sarcomere assembly, and reorganization of the Golgi apparatus,
that accompany differentiation. However, the results of our ex-
periments suggest an alternative interpretation of the phenome-
non and rather indicate the existence of a defined pathway that
actively controls cell behavior in response to low nutrients.
AMPK, Nampt, and SIRT1 are the molecular components of
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Effectors of Glucose Restriction in Muscle CellsFigure 6. In Vivo Role of SIRT1 during Fasting
(A) RT-qPCR of UCP-2, UCP-3, PDK4, and CD36 transcripts from hindlimb muscles of WT and SIRT1/ mice fed ad libitum (AL) or fasted for 48 hr. The values of
each transcript were corrected for those of GAPDH transcripts. Error bars represent standard deviations. The RNAs obtained from three (n = 3) animals per
experimental group were analyzed. n-fold induction and p values are indicated in the right panel.
(B) UCP-2, UCP-3, and tubulin immunoblot of extracts derived from hindlimb muscles of WT mice fed AL (lanes1 and 2) or fasted (F) for 48 hr (lanes 3 and 4) and
SIRT1/ mice fed AL (lanes 5 and 6) or fasted (F) for 48 hr (lanes 7 and 8). Muscles derived from two WT and two SIRT1/ animals for each experimental
condition were analyzed.
(C) RT-qPCR of embryonic Myh3 and perinatal Myh8, as well as nonmuscle Myl6 myosin transcripts in WT and SIRT1/ mice. The values of each transcript were
corrected for those of GAPDH transcripts. Error bars represent standard deviations. The RNAs obtained from three (n = 3) animals per experimental group were
analyzed.
(D) MHC perinatal and tubulin immunoblot of extracts derived from hindlimb muscles of WT and SIRT1/ mice. Two WT and two SIRT1/ animals were ana-
lyzed.this pathway, and each of them is required for the cell to respond
to GR. Pharmacological inhibition, RNA interference, or hemi-
zigosity of the single molecular components render skeletal mus-
cle cells oblivious to the calorie-poor microenvironment, allowing
them to differentiate in an otherwise nonpermissive microen-
vironment. As such, the AMPK-Nampt-SIRT1 pathway can be
viewed as a checkpoint that allows the cell to sense and respond
to a scarcity of nutrients in the immediate surroundings (Figure 7I).
Experiments conducted in fasting mice revealed that SIRT1 me-
diates response of some AMPK target genes to nutrient availabil-
ity. Because the contribution of satellite cells to physiological
muscle fiber growth and maintenance in the adult animal is small
(Spalding et al., 2005), it is likely that AMPK and SIRT1 may be dif-
ferently activated and mediate distinct outcomes in cultured
muscle cells exposed to low glucose and in muscles of an adult
fasting animal. Central to the regulation of SIRT1 in cultured cells
and to the functional consequences of GR on cell differentiation is
the modulation of the intracellular [NAD+]:[NADH] ratio and the
NAM levels engendered by GR. These two metabolic parametersDare regulated by the Nampt enzyme of the NAD+ salvage pathway
and are essential to convey cellular response induced by GR. The
likelihood that free cellular NAD+ is regulatory for SIRT1 activity is
suggested by the estimated concentration of free nuclear NAD+,
which approximates Km values of several sirtuins (Bedalov et al.,
2003). Nonetheless, the elevated cytosolic free [NAD+]:[NADH]
ratio (Williamson et al., 1967) makes it unlikely that the enzymatic
activity of SIRT1 is modulated by a generalized increase of the
NAD+. Compartmentalization of the NAD+ biosynthesis (Yang
et al., 2006) may create local gradients—in defined nuclear
chromatin domains or organelles (Yang et al., 2007) —of NAD+,
[NAD+]:[NADH] ratio, and NAM levels that could effectively
regulate SIRT1 and other sirtuins. Indeed, reduction of the NAM
levels obtained via expression of the NNMT in skeletal myoblasts
is sufficient to recapitulate the effects of GR on cell differen-
tiation. Although these findings do not exclude the possibility
that the [NAD+]:[NADH] ratio may be functionally relevant, they
further underscore the important role that NAM exerts in regulat-
ing phenomena controlled by SIRT1 (Anderson et al., 2003).evelopmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc. 669
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Effectors of Glucose Restriction in Muscle CellsFigure 7. AMPK Mediates the Glucose-Restriction-Induced Nampt Transcription
(A) RT-qPCR of Nampt RNA transcripts from C2C12 cells cultured in DM with 25 mM, 5 mM, or 2.5 mM glucose. In all the experiments reported in this figure, the
Nampt values were corrected for those of GAPDH transcripts. Error bars represent standard deviations.
(B) Nampt and GAPDH immunoblot of extracts from C2C12 cells cultured as described in (A).
(C) RT-qPCR of Nampt RNA transcripts from hindlimb muscles of mice (n = 3) subjected to a 48 hr fast (F) or fed AL.
(D) Nampt transcripts from C2C12 cells exposed to AICAR in DM with 25 mM glucose.
(E) Nampt immunoblot of extracts from C2C12 cells exposed to AICAR in DM with 25 mM glucose. Quantification was performed by scanning of the bands
corresponding to the Nampt signal and correction of the values for those obtained from the GAPDH signal (Nampt:GAPDH ratio).
(F) Nampt and GAPDH immunoblot of extracts from C2C12 cells expressing AMPK-DN in DM with 25 mM, 5 mM, or 2.5 mM glucose.
(G) Nampt activity in extracts from control or AMPK-DN-expressing C2C12 cells cultured in DM with 25 mM or 5 mM glucose.
(H) [NAD+]:[NADH] ratio in control or AMPK-DN-expressing C2C12 cells cultured in DM with 25 mM or 5 mM glucose.
(I) Schematic illustration of the GR-AMPK-Nampt-SIRT1 pathway.Nampt expression is increased after several stress stimuli (Yang
et al., 2007). Our experiments provide evidence that AMPK is in-
volved in this regulation. AMPK activation—induced by GR or AI-
CAR—causes the Nampt transcripts to increase in normocaloric
conditions, whereas blockade of AMPK obtained with an AMPK
dominant negative form prevents GR-mediated increased ex-
pression of Nampt. Intriguingly, a genomic region directing
Nampt expression encompasses several putative binding sites
for the forkhead FOXO transcription factors (M.F. and V.S., un-
published data), which are phosphorylated and activated by
AMPK (Greer et al., 2007b). In addition to intracellular Nampt,
a secreted form of Nampt has been described that reportedly ex-
hibits robust NAD+ biosynthetic activity. Importantly, Nampt+/
heterozygous mice show impaired glucose tolerance and re-
duced glucose-stimulated insulin secretion (Revollo et al.,
2007). Modification of the intracellular [NAD+]:[NADH] ratio and
of NAM levels are necessary but not sufficient to mediate the ef-670 Developmental Cell 14, 661–673, May 2008 ª2008 Elsevier Inc.fects of GR and require the enzymatic activity of SIRT1. Increased
expression (Cohen et al., 2004; Nemoto et al., 2004) coupled to
increased SIRT1 activity—as we report here in GR skeletal mus-
cle cells—may be part of a functionally coherent strategy devel-
oped by the cell to cope with reduced nutrient availability. It
seems that increased Nampt expression controls different cellu-
lar outcomes depending on the location of the target sirtuins. In
the case of genotoxic-stress-mediated cell death, the protective
role of Nampt is exerted through the mitochondrial SIRT3 and
SIRT4 (Yang et al., 2006), whereas GR-induced Nampt expres-
sion mediates its effects on the differentiation process of skeletal
muscle cells through the nuclear SIRT1. Whether AMPK has
a role also in the SIRT3-SIRT4-regulated response to genotoxic
stress awaits further investigation.
There is little doubt that calorie restriction has several benefi-
cial outcomes in adult organisms, especially in humans with
a typical Western diet (Hursting et al., 2003). For instance,
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Effectors of Glucose Restriction in Muscle Cellsreduction of calorie intake improves numerous functional in-
dexes and reduces metabolic risks associated with type II diabe-
tes and metabolic syndrome. Intriguingly, alternate-day fasting
(ADF)—a regimen involving 1 day of ad libitum diet followed by
1 day of food withholding or reduction—has also been shown,
though not conclusively, to improve insulin sensitivity, reduce
blood pressure, and increase muscle fat oxidation (Varady and
Hellerstein, 2007). Our study raises the possibility that AMPK-
Nampt-SIRT1 may be the molecular pathway activated by calo-
rie restriction or ADF regimens and by the hypoglycemic agent
metformin, a drug commonly used to treat type II diabetes
(Krentz and Bailey, 2005). Less investigated are the effects of re-
duced caloric intake during embryonic and fetal development,
although it is well known that undernourishment is detrimental
for fetal development with lasting consequences in adulthood.
Earlier studies have shown that the skeletal muscle fiber num-
bers in young mammals (Bedi et al., 1982)—including humans
(Montgomery, 1962)—are reduced after undernutrition of the
mother during gestation and lactation. Interestingly, the mono-
nucleated cells lying within the basal lamina (satellite cells)
were not reduced, but the secondary myotubes were, indicating
that the rate of myoblast differentiation (or proliferation) was im-
paired in the muscles of the undernourished animals (Wilson
et al., 1988). Restoration of normal dietary intake could cor-
rect—within a given time frame—the muscle fibers defect of un-
dernourished animals (Wilson et al., 1988). We speculate that,
functioning as a cellular checkpoint, the AMPK-Nampt-SIRT1
pathway may be activated by reduced nutrient availability to pre-
vent the undertaking of energy-demanding processes—such as
cell differentiation—during calorie-unfavorable conditions and
be inactivated, once nutrients become available, to allow re-
sumption of physiological development.
EXPERIMENTAL PROCEDURES
Cell Culture, Small Molecules, and Retroviral Infection
C2C12 cells were obtained from American Type Culture Collection (ATCC) and
grown in complete Dulbecco’s modified Eagle’s medium (DMEM) medium
supplemented with 20% fetal bovine serum (FBS) (growth medium [GM])
and 100 mg/ml penicillin and streptomycin. When C2C12 were nearly confluent
(60%–70% confluency), they were induced to differentiate in DMEM supple-
mented with 2% horse serum, insulin, transferrin, and selenium (13) (Invitro-
gen) (differentiation medium [DM]) either in normocaloric (25 mM glucose) or
reduced glucose conditions, as indicated in the single experiments. The fusion
index was determined by counting of the number of nuclei present in MHC+
cells per number of total nuclei and expressed as percentage as described
in (Iezzi et al., 2004). Nuclei present in at least five microscopic fields were
counted. NAM and metformin were obtained from Sigma. AICAR and D942,
compound C, and the oleic acid were obtained from Calbiochem. The
Nampt-specific inhibitor FK866 was kindly synthesized by the National Insti-
tute of Mental Health (NIMH) Chemical Synthesis and Drug Supply Program
at the National Institutes of Health (NIH). Retroviruses were generated by
transient transfection of retroviral constructs in Phoenix cells. The viral super-
natants were employed to transduce C2C12 cells. Cells were selected with
2 mg/ml puromycin.
Antibodies, Immunoblotting, and Immunofluorescence
The methods and antibodies employed are reported in the Supplemental Data.
Plasmids, siRNAs, and Retroviral Constructs
The constructs and siRNAs source are described in the Supplemental Data.DExpression Profiling and Data Analysis
The methods are described in the Supplemental Data. A comprehensive anno-
tation of the transcripts identified by genome-wide expression profiling has
been deposited in the GEO database. The accession number is reported in
the Supplemental Data.
RT-qPCR
The methods and the oligonucleotide sequences are reported in the Supple-
mental Data.
Mouse Primary Myoblasts
Skeletal primary myoblasts from 4-week-old wild-type or SIRT1+/129/Sv
mice were isolated and cultured as described in (Caretti et al., 2004). To assay
for the effects of GR on muscle differentiation, cells were plated on gelatin-
coated tissue culture dishes and induced to differentiate in DM supplemented
with either 25 mM or 0.5 mM glucose.
Nampt Enzymatic Activity, NAD+ and NADH Assays,
and HPLC/MALDI/MS Determination of NAM
Detailed protocols for determining Nampt activity, NAD+ and NADH levels, and
HPLC/MALDI/MS evaluation of nicotinamide are reported in the Supplemental
Data.
SIRT1 Deacetylase Activity
SIRT activity was measured with the SIRT1 Fluorimetric Drug Discovery Kit
(Biomol) according to the manufacturer’s instructions with minor modifications
as described in the Supplemental Data.
ATP Measurements
ATP levels were determined as described in the Supplemental Data.
Animal Studies
Six-week-old Balb/c mice were obtained from the Jackson Laboratory and
housed at the animal vivarium of the NIAMS at the NIH. The control group
(n = 3) was fed AL with a standard diet (Harland Tekland extruded diet 2018,
57.26% carbohydrate), whereas the experimental group (n = 3) was fasted for
48 hr before being euthanized. Five-month-old wild-type/CD1 or SIRT1/ ho-
mozygous/CD1 mice (McBurney et al., 2003) (n = 3 for each group) were fed AL
or fasted as described for the Balb/c mice. Water was available to both the con-
trol and fasted animals at all times. The hindlimb muscles from both control and
experimental animals were isolated and immediately frozen in liquid nitrogen
and stored at 80C until RNA or protein extraction. Four-week-old wild-type
or SIRT1+/ heterozygous/129/Sv mice (McBurney et al., 2003) were eutha-
nized, and the hindlimb muscles were isolated and immediately employed to
obtain skeletal myoblast cultures. All the animal studies were conducted in ac-
cordance with the NIH Guide for the Care and Use of Laboratory Animals.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, seven
figures, one table, and Supplemental References and are available at http://
www.developmentalcell.com/cgi/content/full/14/5/661/DC1/.
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